Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

NCT00559364 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency
Chronic Pancreatitis
Pancreatectomy

Interventions

DRUG: Viokase® 16
DRUG: Placebo
DRUG: Proton pump inhibitor (PPI)
DRUG: Omeprazole

Sponsor

Forest Laboratories